Search Within

Fengshen Kuo

Formats
  1. Journal Article (55)
  2. Meeting Abstract (24)
  3. Research Letter (2)
Groups
  1. Surgery (74)
  2. GSK Faculty (64)
  3. Human Oncology and Pathogenesis Program (58)
  4. Sloan Kettering Institute Postdocs (56)
  5. Department of Medicine (54)
  6. Solid Tumor Oncology Division (51)

More Groups

People
  1. Abraham Hakimi (44)
  2. Timothy Chan (42)
  3. Luc Morris (29)
  4. Robert Motzer (24)
  5. Martin Voss (22)
  6. Eduard Reznik (18)

More People

Years
  1. 2025 (9)
  2. 2024 (9)
  3. 2023 (13)
  4. 2022 (15)
  5. 2021 (7)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (6)
  3. Nature Communications (4)
  4. Nature Medicine (4)
  5. Urologic Oncology: Seminars and Original Investigations (4)
  6. Cancer Cell (3)

More Publications

Publishers
  1. Nature Publishing Group (16)
  2. American Society of Clinical Oncology (15)
  3. American Association for Cancer Research (14)
  4. Elsevier Inc. (7)
  5. Cell Press (5)
  6. Oxford University Press (5)

More Publishers

Results (81)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Spatial profiling of urothelial carcinoma with aberrant histology identified significant intratumoral molecular and immune heterogeneity with clinical implications
    Meeting Abstract

    Kuo, F.; Basar, M.; Koll, F.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Gopalan, A.; Fine, S.; Tickoo, S.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas
    Journal Article

    Brust, L. A.; Linxweiler, M.; Schnatmann, J.; Kühn, J. P.; Knebel, M.; Braun, F. L.; Wemmert, S.; Menger, M. D.; Schick, B.; Holick, M. F.; more...
    Biomedicine and Pharmacotherapy (2024)

    Fulltext@MSK | Save
  • Hypoxia-inducible factor-2 alpha (HIF-2α) target activation and clinical outcomes in 942 patients with clear cell renal cell carcinoma
    Meeting Abstract

    Doshi, S. D.; Kuo, F.; Knezevic, A.; Kotecha, R. R.; Motzer, R. J.; Hakimi, A. A.; Voss, M. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Circulating leptin and immune-related transcriptomic patterns in clear cell renal cell carcinoma
    Meeting Abstract

    Posada Calderon, L.; Olsson, L.; Kuo, F.; Dawidek, M.; Barbakoff, D.; Ganz, M.; Jiang, H.; Coleman, J. A.; Russo, P.; Furberg, H.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • The NF-I/a transcription factor is a HIF-independent oncogenic dependency in kidney cancer
    Meeting Abstract

    Scovell, J.; Zayas, S.; Grubb, T.; Kuo, F.; Reznik, E.; Hakimi, A. A.; Chakraborty, A.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Comprehensive immunogenomic evaluation of patients undergoing consolidative cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with immune checkpoint blockade
    Meeting Abstract

    Reese, S.; Yarlagadda, V.; Wu, C. Y.; Kuo, F.; Tang, C.; Jiang, H.; Vuong, L. H.; Eismann, L.; Motzer, R.; Voss, M. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Connexin-26 expression is associated with disease outcomes in clear cell renal cell carcinoma and may be a source of intratumoral adenosine
    Meeting Abstract

    Ellis, E.; Rappold, P.; Kuo, F.; Hakimi, A. A.
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
    Journal Article

    Kotecha, R. R.; Knezevic, A.; Arora, K.; Bandlamudi, C.; Kuo, F.; Carlo, M. I.; Fitzgerald, K. N.; Feldman, D. R.; Shah, N. J.; Reznik, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
    Meeting Abstract

    Vuong, L.; Kuo, F.; Jiang, H.; Mascareno, E. A.; Rappold, P.; Sabio, E.; Weiss, K.; Cornish, A.; Reese, S.; Adlesic, M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save